about
Interventions for treating pulmonary hypertension in people with sickle cell disease or thalassaemiaSildenafil for pulmonary hypertension in neonatesSildenafil for pulmonary hypertension in neonatesFunctional changes in pulmonary arterial endothelial cells associated with BMPR2 mutationsMultidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferationEndothelin antagonists: new bullets against lung injury?Cold hands--strained heart? Advances in the management of Raynaud's phenomenon and pulmonary hypertensionSafety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertensionMedical treatment update on pulmonary arterial hypertensionThe molecular targets of approved treatments for pulmonary arterial hypertensionPathobiology of pulmonary arterial hypertension and right ventricular failureImmune and inflammatory mechanisms in pulmonary arterial hypertensionClinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanPulmonary hypertension in renal disease: epidemiology, potential mechanisms and implicationsOptimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment coursePulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problemsTreprostinil for the treatment of pulmonary arterial hypertensionQuality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertensionThe key role of PGC-1α in mitochondrial biogenesis and the proliferation of pulmonary artery vascular smooth muscle cells at an early stage of hypoxic exposureRole of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertensionPositive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertensionEvolutionary Genetics of Hypoxia Tolerance in Cetaceans during DivingAbnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasoundProtective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-α.Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.Inhaled iloprost in pulmonary arterial hypertension.Anesthetic management of the patient with dilated cardiomyopathy undergoing pulmonary resection surgery: a case-based discussion.Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry.The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic optionsBone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.Optogenetic control of cellular forces and mechanotransduction.Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the artPharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.
P2860
Q24187475-7D989130-43A6-4606-8568-9BB99AB89FA7Q24235010-E48612B0-05EC-4ED6-BCB2-96B35C6E9C70Q24243841-2E2ED81E-6586-4EC3-9308-27814675B186Q24303490-923A7887-DE77-43F5-8340-EFADBBA42FC8Q24641873-43F5D066-5830-41B9-9203-659B096F2AA6Q24811836-8B50F0C4-3A73-4A30-84B4-E371B5D10F39Q24816970-0CF82E86-07BC-4563-874B-93A05CE767E8Q26771505-83D2A8C7-D222-409C-B458-784337478FDCQ26785995-85B6492C-F65A-4ACC-855B-E844E90319CBQ26798308-081CB9E1-D82F-4F28-8B3A-3936F5725C47Q26821779-FBE833BA-ED39-40CD-BAB6-3A20B849BA2CQ26851508-72B70D14-9EA9-4D0E-A4C9-D488E7A52CDEQ26851546-B4C184D3-3A83-4D64-BB07-B3A5372A8E8CQ26996772-EC744477-E3DF-4ABD-B885-27CDF85AB55AQ27023074-4A427CE3-4119-4B18-B8F2-866056775EBAQ27687091-C7643398-17C9-4797-968D-541C2E3A5D83Q28218351-ABAE0CDD-2C17-40BB-BA68-8EDEE3795D98Q28281899-8E477C41-C140-448A-B41C-884B3AE83687Q28544778-828EFEF8-77E8-4625-A27D-FDCEEB08B305Q28572068-9FC06616-6F48-41C5-9095-1DE468AC0F8FQ28577656-E6F9B878-3FF3-4180-B3FA-A2FD8E396E67Q28581184-FFA2CFC9-68A8-40CF-A666-2BEA6B38D760Q28601042-12231498-87E8-4784-BA8A-5C58F1FADAE3Q28730836-EFAD8B6C-250E-4B11-8470-F76A2CFEC326Q29347118-D436634F-4AD4-4D1B-B07E-ADDEE176C2E7Q30251818-1B5EA218-F674-4377-9314-A52FB351A6E1Q30437211-C7E683BA-0766-4F4E-9D78-A130F111CE38Q30455957-E852D3CC-6A3A-4420-8AD1-79292D1ED32BQ30464688-306C0E62-A86B-4140-8BCA-4F036A8AE639Q30473252-58F1B371-3B04-451E-9402-F73ED1030239Q30485381-CDD1403A-641B-42CB-BADC-8E34464C8FB3Q30486054-A994B607-E0FC-4155-A5AC-8F4F1A7CFC18Q30838711-943D2CD6-7E97-49D6-9BEB-DA5204B20C01Q33160867-B8412BFF-5726-4432-81D4-6AA703DA355BQ33165207-0D3BD3BC-2E85-4BBD-98F5-DB76B16E80BEQ33393513-E64C5099-B512-43BE-B0FC-5D1A46216942Q33447738-F0BCA8C3-9968-439D-85DF-439B4D0EA114Q33538017-2328ABAC-700B-4374-8250-3A4A55109609Q33587892-3AAA981B-CC8B-4B1C-89B5-989418CAB447Q33588179-2FFC0356-4C34-4F83-B0DB-FDB10ED0712A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Treatment of pulmonary arterial hypertension.
@ast
Treatment of pulmonary arterial hypertension.
@en
type
label
Treatment of pulmonary arterial hypertension.
@ast
Treatment of pulmonary arterial hypertension.
@en
prefLabel
Treatment of pulmonary arterial hypertension.
@ast
Treatment of pulmonary arterial hypertension.
@en
P356
P1476
Treatment of pulmonary arterial hypertension.
@en
P2093
Gérald Simonneau
P304
P356
10.1056/NEJMRA040291
P407
P577
2004-09-01T00:00:00Z